SOX2 and colorectal carcinoma: Consistent with the previous results, knockdown of SOX2 in the acidic tumor microenvironment weakened the self-renewal ability of CRC stem cells (Fig. 4f; Supplementary Fig. S2d) and strengthened the sensitivity of the cells to oxaliplatin (Fig. 4g).